Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Zimmer

Showing results (61-70 of 218) with videos related to

Pageof 22
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 23, 2017
Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitisCindy Franklin, Isabelle Rooms, Melanie Fiedler, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2013
Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patientsSimone M Goldinger, Lisa Zimmer, Carsten Schulz, et al.
Frontiers in Oncology|September 12, 2022
COVID-19 vaccination in advanced skin cancer patients receiving systemic anticancer treatment: A prospective singlecenter study investigating seroconversion ratesGeorg C Lodde, Melanie Fiedler, Ulf Dittmer, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2019
Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanomaTheodora Kanaki, Andreas Stang, Ralf Gutzmer, et al.
ESC Heart Failure|July 27, 2022
Right ventricular and atrial strain in patients with advanced melanoma undergoing immune checkpoint inhibitor therapyJulia Pohl, Matthias Totzeck, Raluca-I Mincu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 14, 2013
TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomasKlaus G Griewank, Bastian Schilling, Rajmohan Murali, et al.
Cardio-Oncology (London, England)|June 17, 2026
Cardiac dysfunction during immune checkpoint inhibitor therapy: association with extracardiac immune-related adverse eventsRaluca I Mincu, Lena Lampe, Lars Michel, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 28, 2020
Anne Zaremba, Lisa Zimmer, Eleftheria Chorti, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 9, 2020
Fatal swelling of the groin - Clear cell sarcoma: a rare but important differential diagnosis to malignant melanomaAnne Zaremba, Lisa Zimmer, Eleftheria Chorti, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 22, 2025
Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centersMarkus Reitmajer, Elisabeth Livingstone, Lucie Heinzerling, et al.
Pageof 22

Showing results (61-70 of 218) with videos related to

Sort By:
Pageof 22
European Journal of Cancer (Oxford, England : 1990)|October 23, 2017
Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitisCindy Franklin, Isabelle Rooms, Melanie Fiedler, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2013
Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patientsSimone M Goldinger, Lisa Zimmer, Carsten Schulz, et al.
Frontiers in Oncology|September 12, 2022
COVID-19 vaccination in advanced skin cancer patients receiving systemic anticancer treatment: A prospective singlecenter study investigating seroconversion ratesGeorg C Lodde, Melanie Fiedler, Ulf Dittmer, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2019
Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanomaTheodora Kanaki, Andreas Stang, Ralf Gutzmer, et al.
ESC Heart Failure|July 27, 2022
Right ventricular and atrial strain in patients with advanced melanoma undergoing immune checkpoint inhibitor therapyJulia Pohl, Matthias Totzeck, Raluca-I Mincu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 14, 2013
TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomasKlaus G Griewank, Bastian Schilling, Rajmohan Murali, et al.
Cardio-Oncology (London, England)|June 17, 2026
Cardiac dysfunction during immune checkpoint inhibitor therapy: association with extracardiac immune-related adverse eventsRaluca I Mincu, Lena Lampe, Lars Michel, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 28, 2020
Anne Zaremba, Lisa Zimmer, Eleftheria Chorti, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 9, 2020
Fatal swelling of the groin - Clear cell sarcoma: a rare but important differential diagnosis to malignant melanomaAnne Zaremba, Lisa Zimmer, Eleftheria Chorti, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 22, 2025
Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centersMarkus Reitmajer, Elisabeth Livingstone, Lucie Heinzerling, et al.
Pageof 22